Your browser doesn't support javascript.
loading
Impact of the COVID-19 Pandemic on a Cancer Fast-Track Programme.
Martínez, M T; Moragon, S; Ortega-Morillo, B; Montón-Bueno, J; Simon, S; Roselló, S; Insa, A; Viala, A; Navarro, J; Sanmartín, A; Fluixá, C; Julve, A; Soriano, D; Buch, E; Peña, A; Franco, J; Martínez-Jabaloyas, J; Marco, J; Forner, M J; Cano, A; Silvestre, A; Teruel, A; Bermejo, B; Cervantes, A; Chirivella Gonzalez, I.
Afiliación
  • Martínez MT; Department of Medical Oncology Department, Hospital Clínico Universitario, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain.
  • Moragon S; Department of Medical Oncology Department, Hospital Clínico Universitario, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain.
  • Ortega-Morillo B; Department of Medical Oncology Department, Hospital Clínico Universitario, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain.
  • Montón-Bueno J; Department of Medical Oncology Department, Hospital Clínico Universitario, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain.
  • Simon S; Department of Medical Oncology Department, Hospital Clínico Universitario, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain.
  • Roselló S; Department of Medical Oncology Department, Hospital Clínico Universitario, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain.
  • Insa A; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.
  • Viala A; Instituto de Salud Carlos III, CIBERONC, Madrid, Spain.
  • Navarro J; Department of Medical Oncology Department, Hospital Clínico Universitario, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain.
  • Sanmartín A; Department of Medical Oncology Department, Hospital Clínico Universitario, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain.
  • Fluixá C; Management Department, Hospital Clinico Universitario de Valencia, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain.
  • Julve A; CIBERESP (CIBER de Epidemiología y Salud Pública), Centro Nacional de Epidemiología Del Instituto de Salud Carlos III, Madrid, Spain.
  • Soriano D; Management Department, Hospital Clinico Universitario de Valencia, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain.
  • Buch E; Alfahuir Primare Care Center, Valencia, Spain.
  • Peña A; Department of Radiodiagnosis, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.
  • Franco J; Department of Radiodiagnosis, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.
  • Martínez-Jabaloyas J; Department of Surgery, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.
  • Marco J; Department of Medicine Digestive, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.
  • Forner MJ; Department of Pneumology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.
  • Cano A; Department of Urology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.
  • Silvestre A; Department of Otolaryngology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.
  • Teruel A; Department of Internal Medicine, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.
  • Bermejo B; Department of Gynaecology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.
  • Cervantes A; Department of Traumatology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.
  • Chirivella Gonzalez I; Department of Haematology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.
Cancer Control ; 29: 10732748221131000, 2022.
Article en En | MEDLINE | ID: mdl-36355430

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Cancer Control Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Cancer Control Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos